KRAS inhibitors: going noncovalent

Drosten, M; Barbacid, M

Drosten, M (通讯作者)，Ctr Investigaciondel Canc CIC, Mech Canc Program, Campus Unamuno S-N, Salamanca 37007, Spain.;Drosten, M (通讯作者)，CSIC USAL, Inst Biologia Mol & Celular Canc IBMCC, Campus Unamuno S-N, Salamanca 37007, Spain.;Barbacid, M (通讯作者)，Ctr Nacl Invest Oncol CNIO, Mol Oncol Program, Melchor Fernandez Almagro 3, Madrid 28029, Spain.

MOLECULAR ONCOLOGY, 2022; 16 (22): 3911

Abstract

KRAS(G12D) is the most frequent KRAS mutation in human cancer with particularly high frequencies in pancreatic and colorectal cancer. Informed by the ......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索